| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 150.16B | 145.20B | 138.46B | 131.24B | 110.95B | 101.77B |
| Gross Profit | 42.95B | 41.10B | 39.16B | 35.09B | 34.08B | 30.52B |
| EBITDA | 19.62B | 16.23B | 17.48B | 13.97B | 16.21B | 10.68B |
| Net Income | 10.28B | 8.41B | 7.99B | 6.95B | 11.69B | 3.37B |
Balance Sheet | ||||||
| Total Assets | 237.33B | 225.83B | 225.05B | 201.91B | 185.76B | 180.02B |
| Cash, Cash Equivalents and Short-Term Investments | 30.69B | 24.95B | 19.98B | 17.66B | 27.07B | 25.94B |
| Total Debt | 65.59B | 68.94B | 68.06B | 52.92B | 46.83B | 58.04B |
| Total Liabilities | 121.73B | 111.38B | 118.93B | 104.48B | 93.89B | 100.50B |
| Stockholders Equity | 115.41B | 114.27B | 106.07B | 97.43B | 91.87B | 79.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.53B | -10.35B | -10.64B | 12.02B | -1.40B |
| Operating Cash Flow | 0.00 | 18.33B | -2.81B | -6.02B | 16.50B | 4.75B |
| Investing Cash Flow | 0.00 | -11.41B | -7.04B | -5.02B | -4.32B | -6.16B |
| Financing Cash Flow | 0.00 | -2.34B | 11.52B | 1.05B | -11.60B | 6.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥119.27B | 10.07 | ― | 3.72% | 5.40% | 14.80% | |
76 Outperform | ¥79.99B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
70 Outperform | ¥114.35B | 6.63 | ― | 4.15% | 1.16% | 167.89% | |
69 Neutral | ¥2.37T | 13.66 | 11.64% | 1.52% | 9.81% | 32.64% | |
68 Neutral | ¥421.81B | 7.90 | 13.71% | 3.38% | 0.29% | 27.84% | |
65 Neutral | ¥357.80B | 10.69 | 8.14% | 2.61% | -1.45% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |